Thư viện tập trung - Thư viện điện tử

Sách, tuyển tập

Technical Advisory Group on Tuberculosis for the WHO European Region: report of the 13th Meeting: 9–10 April 2019, Copenhagen, Denmark / World Health Organization. Regional Office for Europe

Tác giả : World Health Organization. Regional Office for Europe

Nhà xuất bản : World Health Organization. Regional Office for Europe

Năm xuất bản : 2019

Chủ đề : 1. Europe. 2. Health Plan Implementation. 3. Organization and Administration. 4. Strategic Planning. 5. Tuberculosis. 6. Technical documents.

Chia sẻ

Thông tin chi tiết

Tóm tắt :

19 p. This meeting reviewed progress in implementing the recommendations of the 18th Meeting of the Strategic and Technical Advisory Group for Tuberculosis (STAG-TB) and the previous TAG-TB meeting.TAG-TB congratulated WHO/Europe and European Member States for their effective actions which have resulted in a decreasing trend of TB incidence rates across many countries. It also pointed out concerning issues to address, including the increasing proportion of multidrug and extensively drug-resistant TB (M/XDR-TB), the growing number of TB/HIV coinfection cases and the challenges in reforming health-care systems towards ambulatory TB care.RecommendationsTB and universal health coverage (UHC): To support countries’ efforts to end TB under UHC, TAG-TB recommended that WHO/Europe provide policy guidance to Member States in framing TB within a UHC perspective.Sustainability of TB prevention and care: Many countries in the Region need to prepare for declining donor support and ensure the financial sustainability of TB prevention, treatment and care. TAG-TB recommended that eligible countries undertake a series of integrated actions, listed in the report.Multisectoral accountability framework (MAF): To make the regional MAF operational, a minimum set of new indicators to be collected and reported on needs to be defined. TAG-TB recommended that WHO/Europe work with Member States to finalize the data collection list, develop tools for collecting MAF data and convene a working group to discuss and promote the MAF and its regional adaptation. This group should involve TAG-TB and engage relevant stakeholders. TAG-TB also recommended that WHO/Europe extend the Tuberculosis Action Plan for the WHO European Region 2016–2020 beyond 2020, and link it with the MAF and its regional adaptation.Other areas: TAG-TB provided recommendations on TB and M/XDR-TB, latent TB infection and TB prevention, the TB Consilium, TB/hepatitis C coinfection, and childhood TB formulations.

Chia sẻ

Hiển thị MARC

Thông tin dữ liệu nguồn

Thư viện	Ký hiệu xếp giá	Dữ liệu nguồn
Tổ chức y tế thế giới		https://iris.who.int/handle/10665/347380

Ldr		00025nam a2200024 a 4500
001		CLN251783362
041	__	$aen
100	__	$aWorld Health Organization. Regional Office for Europe
245	__	$aTechnical Advisory Group on Tuberculosis for the WHO European Region: report of the 13th Meeting: 9–10 April 2019, Copenhagen, Denmark /$cWorld Health Organization. Regional Office for Europe
260	__	$bWorld Health Organization. Regional Office for Europe ,$c2019
520	__	$a19 p.
520	__	$aThis meeting reviewed progress in implementing the recommendations of the 18th Meeting of the Strategic and Technical Advisory Group for Tuberculosis (STAG-TB) and the previous TAG-TB meeting.TAG-TB congratulated WHO/Europe and European Member States for their effective actions which have resulted in a decreasing trend of TB incidence rates across many countries. It also pointed out concerning issues to address, including the increasing proportion of multidrug and extensively drug-resistant TB (M/XDR-TB), the growing number of TB/HIV coinfection cases and the challenges in reforming health-care systems towards ambulatory TB care.RecommendationsTB and universal health coverage (UHC): To support countries’ efforts to end TB under UHC, TAG-TB recommended that WHO/Europe provide policy guidance to Member States in framing TB within a UHC perspective.Sustainability of TB prevention and care: Many countries in the Region need to prepare for declining donor support and ensure the financial sustainability of TB prevention, treatment and care. TAG-TB recommended that eligible countries undertake a series of integrated actions, listed in the report.Multisectoral accountability framework (MAF): To make the regional MAF operational, a minimum set of new indicators to be collected and reported on needs to be defined. TAG-TB recommended that WHO/Europe work with Member States to finalize the data collection list, develop tools for collecting MAF data and convene a working group to discuss and promote the MAF and its regional adaptation. This group should involve TAG-TB and engage relevant stakeholders. TAG-TB also recommended that WHO/Europe extend the Tuberculosis Action Plan for the WHO European Region 2016–2020 beyond 2020, and link it with the MAF and its regional adaptation.Other areas: TAG-TB provided recommendations on TB and M/XDR-TB, latent TB infection and TB prevention, the TB Consilium, TB/hepatitis C coinfection, and childhood TB formulations.
650	_2	$aTuberculosis
650	_2	$aStrategic Planning
650	_2	$aOrganization and Administration
650	_2	$aHealth Plan Implementation
650	_2	$aEurope
655	__	$aTechnical documents
856	__	$uhttps://iris.who.int/handle/10665/347380
900		1
907		https://iris.who.int/bitstream/handle/10665/347380/WHO-EURO-2019-3716-43475-61072-eng.pdf.jpg?sequence=4&isAllowed=y
925		G
926		0
927		SH

Technical Advisory Group on Tuberculosis for the WHO European Region: report of the 13th Meeting: 9–10 April 2019, Copenhagen, Denmark / World Health Organization. Regional Office for Europe

Thông tin dữ liệu nguồn

Tài liệu cùng tác giả

Roadmap to professionalizing the public health workforce in the European Region / World Health Organization. Regional Office for Europe

Factsheet for health workers. Job aid for COVID-19 vaccine administration: paediatric formulation of Pfizer–BioNTech COVID-19 vaccine, BNT162b2: February 2022 / World Health Organization. Regional Office for Europe

Job aid for COVID-19 vaccine administration: paediatric formulation of Pfizer–BioNTech COVID-19 vaccine, BNT162b2: February 2022 / World Health Organization. Regional Office for Europe

Nurse workforce sustainability in small countries: monitoring mobility, managing retention. Policy brief / World Health Organization. Regional Office for Europe

Health in prisons - COVID-19. Minimum dataset: summary of data reported from May 2020 to October 2021 / World Health Organization. Regional Office for Europe

Lời ngỏ

Mục đích và phương châm hoạt động

Bản quyền